{"product_id":"clinical-laboratory-kpi-metrics","title":"7 Critical KPIs for Clinical Laboratory Profitability","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Clinical Laboratory\u003c\/h2\u003e\n\u003cp\u003eThe Clinical Laboratory business model is defined by high initial capital expenditures and substantial fixed operating costs Your variable costs—reagents and logistics—start near 190% of revenue in 2026 (140% COGS + 50% OpEx) This leaves a high gross margin, but fixed overhead, including $50,208 in monthly wages and $22,800 in facility costs, totals about $73,000 monthly To succeed in 2026, you must aggressively manage capacity utilization, which starts around 650% for Lab Scientists This guide details 7 core KPIs—from Revenue Per Test to Accounts Receivable Days—that you must review weekly and monthly to ensure the $1 million initial capital investment pays off\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eClinical Laboratory\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eRevenue Per Test (RPT)\u003c\/td\u003e\n\u003ctd\u003eFinancial Ratio\u003c\/td\u003e\n\u003ctd\u003eOptimize test mix toward specialized assays\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eGross Margin %\u003c\/td\u003e\n\u003ctd\u003eProfitability\u003c\/td\u003e\n\u003ctd\u003eTarget greater than 75%\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eTest Volume per FTE\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eMaximize use of Lab Scientists and Technicians\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eCapacity Utilization Rate\u003c\/td\u003e\n\u003ctd\u003eOperational Efficiency\u003c\/td\u003e\n\u003ctd\u003eRoom for growth indicated by 650% utilization in 2026\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eAccounts Receivable Days (ARD)\u003c\/td\u003e\n\u003ctd\u003eCash Flow\u003c\/td\u003e\n\u003ctd\u003eTarget less than 45 days\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eError Rate Percentage\u003c\/td\u003e\n\u003ctd\u003eQuality Control\u003c\/td\u003e\n\u003ctd\u003eCrucial for CLIA compliance and physician trust\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eEBITDA Margin %\u003c\/td\u003e\n\u003ctd\u003eOperating Performance\u003c\/td\u003e\n\u003ctd\u003eValidate scale based on projected $249M EBITDA by 2030\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do we maximize revenue per test while maintaining payer acceptance?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eTo maximize revenue per test for your Clinical Laboratory, you must actively manage your test mix to favor high-margin specialized assays while rigorously tracking payer reimbursement against your fee-for-service pricing tiers. If you don't manage this mix, profitability suffers, defintely, regardless of volume; you can see why understanding the current landscape is key: \u003ca href=\"\/blogs\/profitability\/clinical-laboratory\"\u003eIs The Clinical Laboratory Business Currently Generating Consistent Profits?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAnalyze Payer Acceptance \u0026amp; Pricing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMap every payer’s contracted rate against your established fee-for-service price list.\u003c\/li\u003e\n\u003cli\u003eReimbursement variance is the single biggest drag on your true revenue per test.\u003c\/li\u003e\n\u003cli\u003eIf onboarding new practices takes 14+ days, your churn risk rises quickly.\u003c\/li\u003e\n\u003cli\u003eFocus on the net realized rate, not just the gross billed amount.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eShift to High-Margin Assays\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentify assays where your cost-to-perform is low but reimbursement is high.\u003c\/li\u003e\n\u003cli\u003ePrioritize Infectious Disease Molecular testing, which usually carries a \u003cstrong\u003ehigher margin\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eCalculate the gross profit dollar contribution for your top 10 tests monthly.\u003c\/li\u003e\n\u003cli\u003eAim for \u003cstrong\u003e60%\u003c\/strong\u003e of volume coming from tests with a net margin above \u003cstrong\u003e45%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the true cost of goods sold (COGS) per test type?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou must immediately calculate the variable cost components—reagents, consumables, and direct labor—for every test type to tackle the projected \u003cstrong\u003e140% COGS\u003c\/strong\u003e for 2026. Understanding these granular costs is foundational, much like defining your core operational needs when you map out \u003ca href=\"\/blogs\/write-business-plan\/clinical-laboratory\"\u003eWhat Are The Key Sections To Include In Your Business Plan For Launching The Clinical Laboratory?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePinpoint Variable Test Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCalculate reagent cost per assay run, tracking specific lot usage.\u003c\/li\u003e\n\u003cli\u003eQuantify consumables like pipette tips and specialized tubes per sample.\u003c\/li\u003e\n\u003cli\u003eMeasure direct labor time; for instance, a complex molecular panel might take \u003cstrong\u003e6 minutes\u003c\/strong\u003e of technician time.\u003c\/li\u003e\n\u003cli\u003eThis detailed breakdown shows precisely where the cost of service delivery sits.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDrive Down 2026 COGS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e140% COGS\u003c\/strong\u003e target for 2026 is a major red flag; aim for \u003cstrong\u003e35%\u003c\/strong\u003e max.\u003c\/li\u003e\n\u003cli\u003eIdentify the top \u003cstrong\u003e3\u003c\/strong\u003e highest volume tests that drive the most material spend.\u003c\/li\u003e\n\u003cli\u003eUse projected volume growth to negotiate \u003cstrong\u003e15%\u003c\/strong\u003e volume discounts on those high-use reagents now.\u003c\/li\u003e\n\u003cli\u003eIf a key reagent costs \u003cstrong\u003e$15.00\u003c\/strong\u003e per test, a 15% cut saves \u003cstrong\u003e$2.25\u003c\/strong\u003e per sample; this is defintely where margin is built.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we utilizing our staff and expensive equipment efficiently?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou must immediately measure sample throughput against your Full-Time Equivalent (FTE) capacity because starting Lab Scientist capacity at \u003cstrong\u003e650%\u003c\/strong\u003e suggests either extreme overstaffing or a fundamental flaw in volume forecasting; understanding these operational metrics is crucial before finalizing your \u003ca href=\"\/blogs\/write-business-plan\/clinical-laboratory\"\u003eWhat Are The Key Sections To Include In Your Business Plan For Launching The Clinical Laboratory?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaff Utilization Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCalculate samples processed per FTE per week; this is your true capacity metric.\u003c\/li\u003e\n\u003cli\u003eIf capacity is 650%, you defintely need 6.5 times current volume to justify staffing levels.\u003c\/li\u003e\n\u003cli\u003eTrack scientist time spent on testing versus non-billable prep work.\u003c\/li\u003e\n\u003cli\u003eHigh FTE cost per test signals poor scheduling or low test complexity mix.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eEquipment \u0026amp; Speed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMonitor equipment downtime for major analyzers in hours per month.\u003c\/li\u003e\n\u003cli\u003eA consistent \u003cstrong\u003eTurnaround Time (TAT)\u003c\/strong\u003e is your primary service differentiator.\u003c\/li\u003e\n\u003cli\u003eIf TAT varies by more than \u003cstrong\u003e10%\u003c\/strong\u003e day-to-day, investigate sample flow bottlenecks immediately.\u003c\/li\u003e\n\u003cli\u003eExpensive automation must run near \u003cstrong\u003e90%\u003c\/strong\u003e uptime to cover fixed depreciation costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much working capital is needed to cover the significant initial capital expenditure?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eWorking capital planning for the Clinical Laboratory must focus on bridging the cash gap created by the \u003cstrong\u003e$985,000\u003c\/strong\u003e equipment purchase in early 2026, ensuring you maintain liquidity above the \u003cstrong\u003e$176,000\u003c\/strong\u003e minimum cash floor. This means tight control over Accounts Receivable (AR) days immediately following that major outlay, which directly impacts how much an owner typically makes from a Clinical Laboratory business like this \u003ca href=\"\/blogs\/how-much-makes\/clinical-laboratory\"\u003eHow Much Does An Owner Typically Make From A Clinical Laboratory Business Like This?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eManaging the 2026 Equipment Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e$985,000\u003c\/strong\u003e capital expenditure hits in early 2026.\u003c\/li\u003e\n\u003cli\u003eMonitor cash runway closely after this date.\u003c\/li\u003e\n\u003cli\u003eDo not let cash reserves dip below the \u003cstrong\u003e$176,000\u003c\/strong\u003e safety threshold.\u003c\/li\u003e\n\u003cli\u003eThis requires accurate forecasting of test volume realization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eControlling Cash Inflow Velocity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAccounts Receivable (AR) days are the primary short-term lever.\u003c\/li\u003e\n\u003cli\u003eIf AR days stretch past \u003cstrong\u003e45 days\u003c\/strong\u003e, cash burn accelerates fast.\u003c\/li\u003e\n\u003cli\u003eTarget specialty clinics that pay within \u003cstrong\u003e30 days\u003c\/strong\u003e consistently.\u003c\/li\u003e\n\u003cli\u003eNegotiate payment terms with new physician groups upfront.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eTo offset the $73,000 in monthly fixed overhead, achieving a Gross Margin consistently above 75% by controlling variable costs (projected near 140% of revenue) is the most critical financial goal.\u003c\/li\u003e\n\n\u003cli\u003eAggressively managing capacity utilization, especially the starting 650% utilization for Lab Scientists, is non-negotiable for efficiently covering high fixed costs and ensuring the initial $1 million investment yields returns.\u003c\/li\u003e\n\n\u003cli\u003eMaximizing Revenue Per Test (RPT) by strategically prioritizing high-margin specialized assays must be balanced against controlling the true Cost of Goods Sold (COGS) for every test type performed.\u003c\/li\u003e\n\n\u003cli\u003eGiven the substantial initial capital expenditure, closely monitoring Accounts Receivable Days (ARD) to ensure timely collection below 45 days is vital for maintaining a stable cash runway throughout 2026.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eRevenue Per Test (RPT)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eRevenue Per Test (RPT) tells you the average dollar amount you collect for every diagnostic test completed. This metric is vital because it directly reflects your service mix; a higher RPT signals a successful shift toward specialized, higher-margin assays over routine panels. You need a high RPT to cover the significant fixed costs associated with running a modern clinical laboratory.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows the financial impact of shifting volume to specialized assays.\u003c\/li\u003e\n\u003cli\u003eActs as a direct proxy for overall service profitability potential.\u003c\/li\u003e\n\u003cli\u003eSimplifies revenue forecasting based on test throughput goals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan hide declining overall test volume if specialized tests mask the drop.\u003c\/li\u003e\n\u003cli\u003eIgnores the underlying cost structure (COGS) of the specific tests sold.\u003c\/li\u003e\n\u003cli\u003eA high RPT might result from billing errors or slow collection cycles, not operational excellence.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBenchmarks vary significantly depending on the lab's focus. Routine testing facilities might see RPT in the \u003cstrong\u003e$30–$75\u003c\/strong\u003e range, while specialized molecular or pathology labs focusing on complex diagnostics can push RPT well over \u003cstrong\u003e$200\u003c\/strong\u003e. Tracking RPT against your peer group helps confirm if your service offering is priced competitively or if you're leaving money on the table.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eActively promote specialized assays to ordering physicians to shift the test mix.\u003c\/li\u003e\n\u003cli\u003eReview payer contracts to ensure high-value tests are reimbursed optimally.\u003c\/li\u003e\n\u003cli\u003eImprove turnaround time (TAT) specifically for complex tests to drive adoption.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculate RPT by dividing your total realized revenue from testing services by the total number of tests successfully completed in that period. This gives you the average realized price per unit of service.\u003c\/p\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in March, your lab generated \u003cstrong\u003e$1,500,000\u003c\/strong\u003e in total revenue from all completed diagnostic tests. You processed exactly \u003cstrong\u003e20,000\u003c\/strong\u003e tests that month. The math shows your average realized revenue per test was \u003cstrong\u003e$75\u003c\/strong\u003e. If your average routine test is $50 and specialized tests are $150, this $75 average tells you exactly what proportion of your volume is high-value; defintely focus on pushing that number higher.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eTotal Revenue \/ Total Tests\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment RPT by test category: routine, specialized, and molecular.\u003c\/li\u003e\n\u003cli\u003eTrack RPT against the target cost structure for the current test mix.\u003c\/li\u003e\n\u003cli\u003eEnsure billing codes accurately reflect the complexity of every assay run.\u003c\/li\u003e\n\u003cli\u003eIf RPT declines, immediately review the volume distribution for the prior month.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin %\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage shows how much money is left after paying for the direct costs of running tests, which we call Cost of Goods Sold (COGS). This metric is key because it tells you if your core service delivery is profitable before considering overhead like rent or salaries. Hitting the target proves you can cover your variable costs effectively.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows pricing power relative to direct material and labor costs.\u003c\/li\u003e\n\u003cli\u003eIdentifies efficiency gaps in supply chain or testing processes.\u003c\/li\u003e\n\u003cli\u003eDirectly impacts the cash available to cover fixed operating expenses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores critical fixed costs like specialized equipment depreciation.\u003c\/li\u003e\n\u003cli\u003eCan be manipulated by aggressive revenue recognition timing.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for quality failures, like the Error Rate Percentage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor clinical labs, a healthy Gross Margin % often needs to exceed \u003cstrong\u003e75%\u003c\/strong\u003e to support high capital expenditure and regulatory burdens. Since your initial direct costs (reagents, logistics) start near \u003cstrong\u003e140%\u003c\/strong\u003e of revenue, achieving this benchmark requires rapid cost control. This margin level is essential for scaling beyond initial operational hurdles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate bulk purchasing agreements for high-volume reagents.\u003c\/li\u003e\n\u003cli\u003eOptimize logistics routing to reduce sample transport costs per test.\u003c\/li\u003e\n\u003cli\u003eShift test mix toward higher-margin, specialized assays.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Gross Margin by taking total revenue and subtracting the direct costs associated with generating that revenue, then dividing by revenue. This tells you the percentage of every dollar you keep before paying for your office staff or software.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGross Margin % = (Revenue - COGS) \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo see the required cost structure, let's assume you hit the \u003cstrong\u003e75%\u003c\/strong\u003e target. If total revenue for the month is \u003cstrong\u003e$500,000\u003c\/strong\u003e, your Cost of Goods Sold (COGS) must be no more than \u003cstrong\u003e$125,000\u003c\/strong\u003e. This is a huge drop from the starting point where costs were \u003cstrong\u003e140%\u003c\/strong\u003e of revenue, which defintely shows the operational challenge ahead.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGross Margin % = ($500,000 - $125,000) \/ $500,000 = \u003cstrong\u003e75%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack reagent cost per specific test panel, not just total spend.\u003c\/li\u003e\n\u003cli\u003eSegment COGS into materials, direct labor, and logistics components.\u003c\/li\u003e\n\u003cli\u003eIf margin dips below \u003cstrong\u003e60%\u003c\/strong\u003e, immediately review payer contracts or volume assumptions.\u003c\/li\u003e\n\u003cli\u003eInitial negative margins (starting near \u003cstrong\u003e-40%\u003c\/strong\u003e if costs are 140%) are expected; focus on the trajectory.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eTest Volume per FTE\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTest Volume per FTE measures how many diagnostic tests your staff processes daily or monthly. This metric directly evaluates the productivity of your \u003cstrong\u003eLab Scientists\u003c\/strong\u003e and \u003cstrong\u003eTechnicians\u003c\/strong\u003e. Keeping this number high is critical because labor is often the largest controllable operating expense in a lab setting.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentifies staffing needs accurately before scaling operations.\u003c\/li\u003e\n\u003cli\u003eDirectly links labor spend to output, controlling cost of service delivery.\u003c\/li\u003e\n\u003cli\u003eHighlights efficiency gaps if utilization lags behind automation gains.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores test complexity; a simple test counts the same as a specialized assay.\u003c\/li\u003e\n\u003cli\u003eCan pressure staff into rushing, increasing the Error Rate Percentage.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for non-testing administrative or quality assurance FTEs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBenchmarks vary widely based on test complexity and automation level. High-throughput labs often aim for \u003cstrong\u003ethousands\u003c\/strong\u003e of tests per FTE annually, whereas specialized testing facilities might see significantly lower figures. Tracking against peers shows if your operational setup efficiently converts headcount into billable output.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAutomate repetitive pre-analytical steps to free up Lab Scientists.\u003c\/li\u003e\n\u003cli\u003eImplement shift scheduling based on predicted daily test volume peaks.\u003c\/li\u003e\n\u003cli\u003eCross-train Technicians to handle multiple instrument platforms efficiently.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculating this metric shows the average output per person.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTotal Tests Per Period \/ Total Lab FTEs in Period\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAssume \u003cstrong\u003e150,000\u003c\/strong\u003e total tests performed in Q1 2025, supported by \u003cstrong\u003e25\u003c\/strong\u003e full-time equivalent (FTE) lab staff. If you ran \u003cstrong\u003e150,000\u003c\/strong\u003e tests in Q1 2025 with \u003cstrong\u003e25\u003c\/strong\u003e FTEs supporting the lab floor, your volume per FTE is 6,000.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n150,000 Total Tests \/ 25 Lab FTEs = 6,000 Tests per FTE\n\u003c\/div\u003e\n\u003cp\u003eThis calculation gives you a quarterly benchmark for direct labor efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment FTEs: Separate testing staff from quality control and maintenance staff.\u003c\/li\u003e\n\u003cli\u003eTrack weekly trends; monthly averages smooth out crucial operational spikes.\u003c\/li\u003e\n\u003cli\u003eUse this KPI alongside Capacity Utilization Rate for a full picture.\u003c\/li\u003e\n\u003cli\u003eIf volume per FTE drops, investigate process bottlenecks defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eCapacity Utilization Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCapacity Utilization Rate shows how much of your available testing capacity is actually being used. For the clinical laboratory, this metric tracks the volume of \u003cstrong\u003eActual Tests\u003c\/strong\u003e run against the \u003cstrong\u003eMaximum Potential Tests\u003c\/strong\u003e your current setup can handle. High utilization signals efficient use of expensive lab equipment and staff time.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints when capital investment in new machinery is truly necessary.\u003c\/li\u003e\n\u003cli\u003eHelps justify headcount planning for Lab Scientists and Technicians.\u003c\/li\u003e\n\u003cli\u003eReveals operational slack that can be filled by increasing test volume.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eExtremely high rates can hide impending equipment failure or staff burnout.\u003c\/li\u003e\n\u003cli\u003eIt ignores the mix of tests; running many simple tests inflates the rate misleadingly.\u003c\/li\u003e\n\u003cli\u003eIf the maximum potential baseline is set too low, the metric is useless for strategic planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn many process industries, utilization above \u003cstrong\u003e90%\u003c\/strong\u003e is often the target for cost efficiency. However, for specialized clinical labs, benchmarks are tricky because downtime for calibration and regulatory checks is mandatory. You must define your own realistic maximum potential based on scheduled maintenance windows, not just theoretical machine speed.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eOptimize the testing schedule to minimize instrument changeover time between assays.\u003c\/li\u003e\n\u003cli\u003eImplement automated sample handling to increase throughput without adding FTEs.\u003c\/li\u003e\n\u003cli\u003eFocus sales efforts on practices that can reliably feed consistent, high-volume test panels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculate this by dividing the total number of tests actually processed during a period by the absolute maximum number of tests the lab could have processed in that same period, assuming 100% operational efficiency.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCapacity Utilization Rate = (Actual Tests \/ Maximum Potential Tests)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe projection shows Lab Scientists starting at \u003cstrong\u003e650%\u003c\/strong\u003e utilization in 2026. If we define the baseline Maximum Potential Tests (100% capacity) for that year as \u003cstrong\u003e10,000\u003c\/strong\u003e tests per month based on current fixed assets, the required actual volume to hit that projection is 6.5 times that baseline.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n650% Utilization = (65,000 Actual Tests \/ 10,000 Maximum Potential Tests)\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e650%\u003c\/strong\u003e figure is a strong signal; it means the growth strategy relies heavily on adding capacity or achieving massive efficiency gains beyond the current physical limits, or that the baseline definition of 'Maximum Potential' is very conservative.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment utilization by specific testing platform, not just the lab total.\u003c\/li\u003e\n\u003cli\u003eIf utilization exceeds \u003cstrong\u003e100%\u003c\/strong\u003e, confirm you aren't masking quality issues with speed.\u003c\/li\u003e\n\u003cli\u003eReview the definition of Maximum Potential Tests quarterly; it should reflect reality.\u003c\/li\u003e\n\u003cli\u003eIf utilization is low, focus on improving Test Volume per FTE, defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eAccounts Receivable Days (ARD)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAccounts Receivable Days (ARD) shows how long, on average, it takes your lab to collect money owed after running a diagnostic test for a provider or patient. For a clinical laboratory making big capital investments in automation and testing machinery, slow collections seriously restrict working capital. You need to get paid fast, targeting \u003cstrong\u003eless than 45 days\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoint payers or clinics dragging out payment cycles.\u003c\/li\u003e\n\u003cli\u003eImprove short-term cash flow forecasting accuracy.\u003c\/li\u003e\n\u003cli\u003eEnsure capital deployed for new testing machinery turns over quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt masks differences between fast government payers and slow commercial ones.\u003c\/li\u003e\n\u003cli\u003eA single large, delayed payment can artificially inflate the average.\u003c\/li\u003e\n\u003cli\u003eIt doesn't measure the risk of the receivable becoming uncollectible (bad debt).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor clinical labs billing providers, the target ARD should be \u003cstrong\u003eunder 45 days\u003c\/strong\u003e. Honestly, given the high cost of advanced diagnostic machinery, anything pushing \u003cstrong\u003e60 days\u003c\/strong\u003e starts creating serious liquidity pressure. This benchmark helps you compare against other specialty labs focused on rapid turnaround times.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAutomate claim scrubbing before submission to cut initial denial rates.\u003c\/li\u003e\n\u003cli\u003eOffer small discounts for prompt payment (e.g., 2\/10 net 30 terms).\u003c\/li\u003e\n\u003cli\u003eSegment payers and dedicate staff to follow up on claims older than \u003cstrong\u003e35 days\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculation requires knowing your total outstanding receivables and how much revenue you generate daily from tests. This metric tells you exactly how long your working capital is tied up waiting for payments from clinics and insurers.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nARD = Average Accounts Receivable \/ Daily Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your total outstanding accounts receivable balance is \u003cstrong\u003e$500,000\u003c\/strong\u003e and your lab generates \u003cstrong\u003e$15,000\nstrong\u0026gt; in revenue every day from delivered treatments, you can find the collection period. This shows that, on average, you wait about five weeks for payment.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nARD = $500,000 \/ $15,000 = 33.33 Days\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment ARD by payer class: Medicare, commercial, self-pay.\u003c\/li\u003e\n\u003cli\u003eReview the \u003cstrong\u003e90+ day aging bucket\u003c\/strong\u003e every Monday morning.\u003c\/li\u003e\n\u003cli\u003eTie A\/R staff incentives directly to reducing days outstanding, defintely.\u003c\/li\u003e\n\u003cli\u003eIf onboarding a new clinic, set a \u003cstrong\u003e30-day\u003c\/strong\u003e initial collection target.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eError Rate Percentage\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Error Rate Percentage shows how often tests fail quality checks or produce wrong results. This metric, calculated as Total Errors divided by Total Tests, is your primary indicator of operational reliability. For a clinical laboratory, keeping this number low directly supports \u003cstrong\u003eCLIA compliance\u003c\/strong\u003e and secures \u003cstrong\u003ephysician trust\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDirectly measures adherence to strict \u003cstrong\u003eCLIA (Clinical Laboratory Improvement Amendments)\u003c\/strong\u003e standards.\u003c\/li\u003e\n\u003cli\u003eHigh accuracy builds essential \u003cstrong\u003ephysician trust\u003c\/strong\u003e, leading to higher test volume retention.\u003c\/li\u003e\n\u003cli\u003eFlags systemic issues in automation or technician training before they become costly recalls.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDoesn't distinguish between minor re-runs and catastrophic critical errors.\u003c\/li\u003e\n\u003cli\u003eFocusing too narrowly can inflate costs through unnecessary re-runs.\u003c\/li\u003e\n\u003cli\u003eExternal factors, like poor sample quality from the clinic, can skew results unfairly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn regulated diagnostic testing, benchmarks aren't just targets; they are regulatory floors. Labs serving critical care must maintain error rates well under \u003cstrong\u003e1%\u003c\/strong\u003e to satisfy auditors and maintain accreditation. Falling outside this narrow band signals immediate regulatory risk, defintely not just poor performance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImplement rigorous, automated quality control checks immediately post-run.\u003c\/li\u003e\n\u003cli\u003eStandardize sample handling protocols across all intake points.\u003c\/li\u003e\n\u003cli\u003eInvest in ongoing, scenario-based training for Lab Scientists and Technicians.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou find the total number of tests that failed or needed repeating. Divide that by every test you ran that month. This gives you the percentage of tests that failed quality gates.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nError Rate Percentage = (Total Errors + Total Re-runs) \/ Total Tests Performed\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in March, you ran \u003cstrong\u003e50,000 tests\u003c\/strong\u003e total. Of those, \u003cstrong\u003e400\u003c\/strong\u003e required a full re-run due to instrument drift, and \u003cstrong\u003e50\u003c\/strong\u003e were critical errors caught internally. We add those up to find total errors before applying the formula.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nError Rate Percentage = (400 + 50) \/ 50,000 = 0.9%\n\u003c\/div\u003e\n\u003cp\u003eThis calculation shows your operational error rate for March was \u003cstrong\u003e0.9%\u003c\/strong\u003e, which is a strong starting point for a new lab.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment errors by test type to isolate problem assays quickly.\u003c\/li\u003e\n\u003cli\u003eTrack the time-to-resolution for critical errors; speed matters here.\u003c\/li\u003e\n\u003cli\u003eEnsure your digital platform flags potential errors before results release.\u003c\/li\u003e\n\u003cli\u003eReview error logs monthly with the quality assurance team, not just operations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eEBITDA Margin %\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEBITDA Margin % shows how much profit you generate from sales before accounting for non-cash items like depreciation or interest expense. It’s your core operating efficiency metric. This number tells founders if the actual business engine is running profitably as it scales up.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows true operational cash generation ability before financing structure.\u003c\/li\u003e\n\u003cli\u003eAllows clean comparison across labs with different levels of capital investment.\u003c\/li\u003e\n\u003cli\u003eThe strong projected growth up to \u003cstrong\u003e$249M by 2030\u003c\/strong\u003e defintely validates the business model scale.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores necessary capital expenditures for high-tech lab equipment.\u003c\/li\u003e\n\u003cli\u003eCan mask poor working capital management, like slow collection of Accounts Receivable Days.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for interest expense if the business takes on debt to fund growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor clinical labs, high margins are expected because the Gross Margin target is over \u003cstrong\u003e75%\u003c\/strong\u003e. While specific EBITDA benchmarks vary based on automation levels, a mature, scaled lab should aim for margins in the \u003cstrong\u003e20% to 35%\u003c\/strong\u003e range, depending on fixed overhead structure. These numbers show if your pricing power covers the high fixed costs of running a compliant lab.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDrive up Revenue Per Test (RPT) by optimizing the test mix toward specialized assays.\u003c\/li\u003e\n\u003cli\u003eIncrease Test Volume per FTE to spread fixed labor costs wider across the organization.\u003c\/li\u003e\n\u003cli\u003eAggressively manage Accounts Receivable Days (ARD) to reduce the cost of carrying receivables.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou find the EBITDA Margin by taking your Earnings Before Interest, Taxes, Depreciation, and Amortization and dividing it by your total revenue. This gives you the percentage of every dollar that remains after core operations.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nEBITDA Margin % = (EBITDA \/ Revenue) x 100\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your projected 2028 revenue hits \u003cstrong\u003e$150 million\u003c\/strong\u003e, and after accounting for all operating expenses except depreciation and interest, your EBITDA is \u003cstrong\u003e$40 million\u003c\/strong\u003e. Here’s the quick math to see your operating efficiency.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nEBITDA Margin % = ($40,000,000 \/ $150,000,000) x 100 = \u003cstrong\u003e26.67%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack EBITDA monthly; don't wait for quarterly filings to spot margin compression.\u003c\/li\u003e\n\u003cli\u003eWatch Capacity Utilization Rate; low usage directly erodes this margin percentage.\u003c\/li\u003e\n\u003cli\u003eEnsure Error Rate Percentage stays low, as re-runs destroy profitability immediately.\u003c\/li\u003e\n\u003cli\u003eIf you see ARD creeping past \u003cstrong\u003e45 days\u003c\/strong\u003e, cash flow will starve operational improvements.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303696474355,"sku":"clinical-laboratory-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/clinical-laboratory-kpi-metrics.webp?v=1782679028","url":"https:\/\/financialmodelslab.com\/products\/clinical-laboratory-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}